A Novel Subepidermal Blistering Disease with Autoantibodies to a 200???kDa antigen of the Basement Membrane Zone, Journal of Investigative Dermatology, vol.106, issue.6, pp.1333-1338, 1996. ,
DOI : 10.1111/1523-1747.ep12349283
Clinical and immunological features and outcome of anti-p200 pemphigoid, British Journal of Dermatology, vol.34, issue.4, pp.776-781, 2016. ,
DOI : 10.1111/j.1346-8138.2007.00208.x
A Comparison of Two Regimens of Topical Corticosteroids in the Treatment of Patients with Bullous Pemphigoid: A Multicenter Randomized Study, Journal of Investigative Dermatology, vol.129, issue.7, pp.1681-1687, 2009. ,
DOI : 10.1038/jid.2008.412
URL : https://hal.archives-ouvertes.fr/hal-00396990
Bullous Pemphigoid in a Renal Transplant Recipient, American Journal of Clinical Dermatology, vol.45, issue.6, pp.197-200, 2009. ,
DOI : 10.4049/jimmunol.175.7.4180
Chronic Renal Graft Rejection-associated Bullous Pemphigoid: A Cross-reactive Immune Response?, Acta Dermato Venereologica, vol.91, issue.1, pp.82-83, 2011. ,
DOI : 10.2340/00015555-0954
URL : https://www.medicaljournals.se/acta/content_files/download.php?doi=10.2340/00015555-0954
Anti-p200 pemphigoid, Journal of the American Academy of Dermatology, vol.71, issue.1, pp.185-191, 2014. ,
DOI : 10.1016/j.jaad.2014.02.036
A Single Cycle of Rituximab for the Treatment of Severe Pemphigus, New England Journal of Medicine, vol.357, issue.6, pp.545-552, 2007. ,
DOI : 10.1056/NEJMoa067752
Long-Term Remissions of Severe Pemphigus After Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response, Science Translational Medicine, vol.20, issue.1, pp.175-230, 2013. ,
DOI : 10.1093/intimm/dxm125
A comprehensive analysis of treatment outcomes in patients with pemphigus vulgaris treated with rituximab, Autoimmunity Reviews, vol.14, issue.4, pp.323-331, 2015. ,
DOI : 10.1016/j.autrev.2014.12.002